BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2153197)

  • 1. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease.
    Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Nakane T; Sugita K; Matsui N
    J Neurosurg; 1990 Feb; 72(2):262-7. PubMed ID: 2153197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of endocrine active and clinically silent corticotropic adenomas by in situ hybridization.
    Lloyd RV; Fields K; Jin L; Horvath E; Kovacs K
    Am J Pathol; 1990 Aug; 137(2):479-88. PubMed ID: 2167013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
    Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ACTH secretion in Cushing's adenoma and clinically silent corticotroph adenoma by cell immunoblot assay.
    Kojima Y; Suzuki S; Yamamura K; Ohhashi G; Yamamoto I
    Endocr J; 2002 Jun; 49(3):285-92. PubMed ID: 12201210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
    Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing's disease with resistance to a high dose-dexamethasone suppression test.
    Mu YM; Takayanagi R; Imasaki K; Ohe K; Ikuyama S; Yanase T; Nawata H
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):301-6. PubMed ID: 9861319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas.
    Stefaneanu L; Kovacs K; Horvath E; Lloyd RV
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):107-13. PubMed ID: 1651583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of absent prohormone convertase 1/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I--immunohistochemical study.
    Ohta S; Nishizawa S; Oki Y; Yokoyama T; Namba H
    Pituitary; 2002; 5(4):221-3. PubMed ID: 14558669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrestrained production of proopiomelanocortin (POMC) and its peptide fragments by pituitary corticotroph adenomas in Cushing's disease.
    Bertagna X
    J Steroid Biochem Mol Biol; 1992 Oct; 43(5):379-84. PubMed ID: 1327071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synthesis and release of CRF and ACTH in ectopic CRF/ACTH-producing tumors].
    Suda T
    Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):17-24. PubMed ID: 7958079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid inhibition of ACTH peptides: small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells.
    Farrell WE; Stewart MF; Clark AJ; Crosby SR; Davis JR; White A
    J Mol Endocrinol; 1993 Feb; 10(1):25-32. PubMed ID: 8383976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why don't corticotroph tumors always produce Cushing's disease?
    García-Martínez A; Cano DA; Flores-Martínez A; Gil J; Puig-Domingo M; Webb SM; Soto-Moreno A; Picó A
    Eur J Endocrinol; 2019 Sep; 181(3):351-361. PubMed ID: 31319379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F1-mediated human POMC expression in ectopic Cushing's syndrome.
    Araki T; Liu NA; Tone Y; Cuevas-Ramos D; Heltsley R; Tone M; Melmed S
    Endocr Relat Cancer; 2016 Nov; 23(11):857-870. PubMed ID: 27935805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas.
    Pereda MP; Lohrer P; Kovalovsky D; Perez Castro C; Goldberg V; Losa M; Chervín A; Berner S; Molina H; Stalla GK; Renner U; Arzt E
    Exp Clin Endocrinol Diabetes; 2000; 108(3):202-7. PubMed ID: 10926317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotroph cell adenoma without typical manifestations of Cushing's disease presenting with cavernous sinus syndrome following pituitary apoplexy.
    Abe M; Sawabe Y; Mochizuki Y; Sunaga S; Izumiyama H; Matsumoto K; Kushima M; Taniyama M; Ban Y; Sano T
    Endocr J; 2001 Aug; 48(4):503-7. PubMed ID: 11603575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism.
    Tahara S; Kurotani R; Ishii Y; Sanno N; Teramoto A; Osamura RY
    Mod Pathol; 2002 Oct; 15(10):1102-5. PubMed ID: 12379758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple cellular forms of corticotrophs in surgically removed pituitary adenomas and periadenomatous tissue in Cushing's disease.
    Martin R; Cetin Y; Fehm HL; Fahlbusch R; Voigt KH
    Am J Pathol; 1982 Mar; 106(3):332-41. PubMed ID: 6278938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.